Patch-clamp studies on muscle from a mouse model of myotonia congenita allowed to conclude that the ideal myotonia therapy would selectively block a sustained Na+ current induced by loss-of-function mutations in the ClC-1 chloride channel and spare the transient Na+ current [184,185]. This evidence concerns the gene CLCN1 and Thomsen and Becker disease.